David Perry, President, CEO & Director, Indigo
Prof. Dr. Heinz-Herbert Fiebig, CEO and Dr. Vincent Vuaroqueaux, CTO,4HF Biotec
Owe Orwar, CEO,Oblique Therapeutics
Thomas Laurita, President, and CEO,NewLeaf Symbiotics
Dan Hausman, CTO, ConvergeHEALTH by Deloitte
R. Mark Adams, CIO, Good Start Genetics, Cambridge, MA
Arne Fleisher, Chief Operations & Engineering Branch (OEB), OCICB, NIAID/NIH
Alan Costello, Venture Investment Leader, NDRC
Yony Feng, Co-founder, CTO & CIO, Peloton Interactive